Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Selective Mechanism-Based Inactivation of CYP3A4 by CYP3cide (PF-04981517) and Its Utility as an In Vitro Tool for Delineating the Relative Roles of CYP3A4 versus CYP3A5 in the Metabolism of Drugs

Robert L. Walsky, R. Scott Obach, Ruth Hyland, Ping Kang, Sue Zhou, Michael West, Kieran F. Geoghegan, Christopher J. Helal, Gregory S. Walker, Theunis C. Goosen and Michael A. Zientek
Drug Metabolism and Disposition September 2012, 40 (9) 1686-1697; DOI: https://doi.org/10.1124/dmd.112.045302
Robert L. Walsky
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Groton, CT (R.L.W., R.S.O., M.W., K.F.G., C.J.H., G.S.W., T.C.G.); Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., San Diego, CA (S.Z., P.K., M.A.Z.); and Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Sandwich, United Kingdom (R.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Scott Obach
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Groton, CT (R.L.W., R.S.O., M.W., K.F.G., C.J.H., G.S.W., T.C.G.); Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., San Diego, CA (S.Z., P.K., M.A.Z.); and Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Sandwich, United Kingdom (R.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth Hyland
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Groton, CT (R.L.W., R.S.O., M.W., K.F.G., C.J.H., G.S.W., T.C.G.); Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., San Diego, CA (S.Z., P.K., M.A.Z.); and Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Sandwich, United Kingdom (R.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ping Kang
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Groton, CT (R.L.W., R.S.O., M.W., K.F.G., C.J.H., G.S.W., T.C.G.); Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., San Diego, CA (S.Z., P.K., M.A.Z.); and Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Sandwich, United Kingdom (R.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sue Zhou
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Groton, CT (R.L.W., R.S.O., M.W., K.F.G., C.J.H., G.S.W., T.C.G.); Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., San Diego, CA (S.Z., P.K., M.A.Z.); and Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Sandwich, United Kingdom (R.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael West
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Groton, CT (R.L.W., R.S.O., M.W., K.F.G., C.J.H., G.S.W., T.C.G.); Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., San Diego, CA (S.Z., P.K., M.A.Z.); and Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Sandwich, United Kingdom (R.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kieran F. Geoghegan
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Groton, CT (R.L.W., R.S.O., M.W., K.F.G., C.J.H., G.S.W., T.C.G.); Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., San Diego, CA (S.Z., P.K., M.A.Z.); and Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Sandwich, United Kingdom (R.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher J. Helal
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Groton, CT (R.L.W., R.S.O., M.W., K.F.G., C.J.H., G.S.W., T.C.G.); Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., San Diego, CA (S.Z., P.K., M.A.Z.); and Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Sandwich, United Kingdom (R.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory S. Walker
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Groton, CT (R.L.W., R.S.O., M.W., K.F.G., C.J.H., G.S.W., T.C.G.); Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., San Diego, CA (S.Z., P.K., M.A.Z.); and Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Sandwich, United Kingdom (R.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theunis C. Goosen
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Groton, CT (R.L.W., R.S.O., M.W., K.F.G., C.J.H., G.S.W., T.C.G.); Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., San Diego, CA (S.Z., P.K., M.A.Z.); and Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Sandwich, United Kingdom (R.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Zientek
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Groton, CT (R.L.W., R.S.O., M.W., K.F.G., C.J.H., G.S.W., T.C.G.); Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., San Diego, CA (S.Z., P.K., M.A.Z.); and Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Sandwich, United Kingdom (R.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 40 (9)
Drug Metabolism and Disposition
Vol. 40, Issue 9
1 Sep 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Selective Mechanism-Based Inactivation of CYP3A4 by CYP3cide (PF-04981517) and Its Utility as an In Vitro Tool for Delineating the Relative Roles of CYP3A4 versus CYP3A5 in the Metabolism of Drugs
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

SELECTIVE INHIBITION OF CYP3A4 BY CYP3cide

Robert L. Walsky, R. Scott Obach, Ruth Hyland, Ping Kang, Sue Zhou, Michael West, Kieran F. Geoghegan, Christopher J. Helal, Gregory S. Walker, Theunis C. Goosen and Michael A. Zientek
Drug Metabolism and Disposition September 1, 2012, 40 (9) 1686-1697; DOI: https://doi.org/10.1124/dmd.112.045302

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

SELECTIVE INHIBITION OF CYP3A4 BY CYP3cide

Robert L. Walsky, R. Scott Obach, Ruth Hyland, Ping Kang, Sue Zhou, Michael West, Kieran F. Geoghegan, Christopher J. Helal, Gregory S. Walker, Theunis C. Goosen and Michael A. Zientek
Drug Metabolism and Disposition September 1, 2012, 40 (9) 1686-1697; DOI: https://doi.org/10.1124/dmd.112.045302
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Determination of Acyl-, O-, and N-Glucuronide
  • TMDD Affects PK of IL-10 Fc-fusion Proteins
  • Uptake as the RDS in Pevonedistat Hepatic Clearance
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics